Hannover Re (FRA:HNR1) has been assigned a €105.60 ($122.79) price target by stock analysts at Barclays in a research note issued on Friday. The brokerage presently has a “sell” rating on the stock. Barclays’ price target would suggest a potential downside of 10.66% from the stock’s previous close.

Several other analysts have also commented on HNR1. Nord/LB set a €118.00 ($137.21) price objective on Hannover Re and gave the company a “neutral” rating in a report on Monday, May 14th. Royal Bank of Canada set a €122.00 ($141.86) price objective on Hannover Re and gave the company a “neutral” rating in a report on Friday, May 18th. Commerzbank set a €112.00 ($130.23) price objective on Hannover Re and gave the company a “neutral” rating in a report on Monday, May 28th. UBS Group set a €110.00 ($127.91) price objective on Hannover Re and gave the company a “neutral” rating in a report on Tuesday, May 29th. Finally, Societe Generale set a €112.00 ($130.23) price objective on Hannover Re and gave the company a “neutral” rating in a report on Tuesday, June 12th. Six research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of €112.54 ($130.86).

Shares of HNR1 opened at €118.20 ($137.44) on Friday. Hannover Re has a 12 month low of €94.75 ($110.17) and a 12 month high of €116.37 ($135.31).

About Hannover Re

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Further Reading: Marijuana Stocks Investing Considerations

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.